Document is current
Any future updates will be listed below
-
Authors
Daoud, Mathieu https://orcid.org/0000-0003-4188-1986
Benhadou, Farida https://orcid.org/0000-0002-4533-8297
Suppa, Mariano https://orcid.org/0000-0002-9266-0342
Sarkis, Anne-Sophie https://orcid.org/0000-0001-9352-5284
Heudens, Stéphanie
Desmarest, Lila https://orcid.org/0009-0005-8392-0658
Njimi, Hassane
Daxhelet, Mathilde https://orcid.org/0000-0003-4506-6989
Nobile, Laura
Karama, Jalila
White, Jonathan M. https://orcid.org/0000-0001-7164-2658
Jemec, Gregor B. E. https://orcid.org/0000-0002-0712-2540
del Marmol, Véronique https://orcid.org/0000-0002-4359-0667
- License Information
-
More Information
Article History
Received: 8 November 2024
Revised: 10 December 2024
Accepted: 20 December 2024
First Online: 7 January 2025
Declarations
:
: Mathieu Daoud has received support for attending meetings and travel by AbbVie and Novartis, and has received honoraria from AbbVie for presentations, and from Novartis for his participation on an advisory board. Laura Nobile has received support for attending meetings and travel by AbbVie and Novartis. Gregor BE Jemec has received honoraria for participation as an investigator from AbbVie, Novartis, Union Therapeutics, Henlez, Sanofi, UCB, Incyte and Boehringer Ingelheim, for participation on advisory boards from Novartis, UCB, Incyte and Boehringer Ingelheim. Véronique del Marmol has received, as payment to her institution, grants or contracts from BMS, MSD, Almirall and Sanofi, consulting fees from BMS, MSD, Novartis, Pierre Fabre, Merck, Sanofi, Almirall, Leo and AbbVie, honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from BMS, MSD, Sanofi, Sun Pharma, Pierre Fabre and Novartis, and support for attending meetings and travel by BMS, MSD, Pierre Fabre and Novartis. Farida Benhadou, Mariano Suppa, Anne-Sophie Sarkis, Stéphanie Heudens, Lila Desmarest, Hassane Njimi, Mathilde Daxhelet, Jalila Karama and Jonathan M White have no conflict of interest to declare.
: All the data used in this study came from the European Registry for Hidradenitis Suppurativa (ERHS), whose project was approved by the Ethics Committee of Hôpital Erasme (Erasme Ethical Committee P2015/071).
: All subjects have given their written informed consent.
